Authors:
ANGLADE P
VYAS S
JAVOYAGID F
HERRERO MT
MICHEL PP
MARQUEZ J
MOUATTPRIGENT A
RUBERG M
HIRSCH EC
AGID Y
Citation: P. Anglade et al., APOPTOSIS AND AUTOPHAGY IN NIGRAL NEURONS OF PATIENTS WITH PARKINSONS-DISEASE, Histology and histopathology, 12(1), 1997, pp. 25-31
Authors:
ANGLADE P
MOUATTPRIGENT A
AGID Y
HIRSCH EC
Citation: P. Anglade et al., SYNAPTIC PLASTICITY IN THE CAUDATE-NUCLEUS OF PATIENTS WITH PARKINSONS-DISEASE, Neurodegeneration, 5(2), 1996, pp. 121-128
Authors:
MOUATTPRIGENT A
KARLSSON JO
AGID Y
HIRSCH EC
Citation: A. Mouattprigent et al., INCREASED M-CALPAIN EXPRESSION IN THE MESENCEPHALON OF PATIENTS WITH PARKINSONS-DISEASE BUT NOT IN OTHER NEURODEGENERATIVE DISORDERS INVOLVING THE MESENCEPHALON - A ROLE IN NERVE-CELL DEATH, Neuroscience, 73(4), 1996, pp. 979-987
Authors:
FAUCHEUX BA
NILLESSE N
DAMIER P
SPIK G
MOUATTPRIGENT A
PIERCE A
LEVEUGLE B
KUBIS N
HAUW JJ
AGID Y
HIRSCH EC
Citation: Ba. Faucheux et al., EXPRESSION OF LACTOFERRIN RECEPTORS IS INCREASED IN THE MESENCEPHALONOF PATIENTS WITH PARKINSON DISEASE, Proceedings of the National Academy of Sciences of the United Statesof America, 92(21), 1995, pp. 9603-9607
Authors:
BOISSIERE F
HUNOT S
FAUCHEUX B
MOUATTPRIGENT A
AGID Y
HIRSCH EC
Citation: F. Boissiere et al., HIGH-AFFINITY NEUROTROPHIN RECEPTORS IN CHOLINERGIC NEURONS IN THE HUMAN BRAIN, Comptes rendus de l'Academie des sciences. Serie 3, Sciences de la vie, 317(11), 1994, pp. 997-1003
Citation: A. Mouattprigent et al., DOES THE CALCIUM-BINDING PROTEIN CALRETININ PROTECT DOPAMINERGIC-NEURONS AGAINST DEGENERATION IN PARKINSONS-DISEASE, Brain research, 668(1-2), 1994, pp. 62-70
Authors:
FAUCHEUX BA
HIRSCH EC
VILLARES J
SELIMI F
MOUATTPRIGENT A
JAVOYAGID F
HAUW JJ
AGID Y
Citation: Ba. Faucheux et al., DISTRIBUTION OF I-125 FERROTRANSFERRIN BINDING-SITES IN THE MESENCEPHALON OF CONTROL SUBJECTS AND PATIENTS WITH PARKINSONS-DISEASE, Journal of neurochemistry, 60(6), 1993, pp. 2338-2341